Current status of surgical treatment in gastric cancer with para-aortic nodal metastases
10.19538/j.cjps.issn1005-2208.2019.07.04
- Author:
Xiang HU
1
Author Information
1. Department of General Surgery,the First Affiliated Hospital of Dalian Medical University Dalian 116011,China
- Publication Type:Journal Article
- Keywords:
stage Ⅳ gastric cancer;
chemotherapy;
conversion therapy;
para-aortic lymph node
- From:
Chinese Journal of Practical Surgery
2019;39(07):659-662
- CountryChina
- Language:Chinese
-
Abstract:
Para-aortic lymph node metastasis(No. 16a2,No.16b1)is a non-curative factors with stage Ⅳ gastric cancer. The prognosis is poor. The high-level evidence based medical clinical research(JCOG0405 trail)results proved that R0 resection can be performed by the technology of operation after systemic preoperative chemotherapy for the patients of stage Ⅳ gastric cancer with only one non-curative factor of para-aortic lymph node metastasis positive. And the satisfactory prognosis was achieved. In this regard,comprehensive treatment including surgical resection is the first choice and standard treatment for the stage Ⅳ gastric cancer with para-aortic lymph node metastasis.
